Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

Journal of Virology

Volumn 76, Issue 12, 2002, Pages 6356-6363

  Addison, William R ^a   Walters, Kathie Anne ^a   Wong, Winnie W S ^a   Wilson, John S ^a   Madej, Danuta ^a   Jewell, Lawrence D ^a   Tyrrell, D Lorne J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIDEOXYGUANOSINE PRODRUG; LAMIVUDINE; PRODRUG; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CONTROLLED STUDY; COVALENT BOND; DIPLOIDY; DNA DETERMINATION; DUCK; GENETIC STABILITY; HALF LIFE TIME; HEPATITIS B VIRUS; IN VIVO STUDY; LIVER BIOPSY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; DNA, CIRCULAR; DNA, VIRAL; DUCKS; FEMALE; HALF-LIFE; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; HEPATITIS, VIRAL, ANIMAL; LIVER; MALE; MOLECULAR SEQUENCE DATA; VIRUS REPLICATION;

EID: 0036109092     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.12.6356-6363.2002     Document Type: Article

References (31)

1. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus
2. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
3. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures
4. Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA
5. A preliminary trial of lamivudine for chronic hepatitis B infection
6. Lamivudine as initial treatment for chronic hepatitis B in the United States
7. Lamivudine: Resistance mechanisms and their clinical implications
8. Generation of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(-)-β-L-2′,3′-dideoxy-3′-thiacytidine] in vitro
9. Alteration of infection pattern of duck hepatitis B virus by immunomodulatory drugs
10. The molecular biology of hepatitis B viruses
11. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance
12. Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2′,3′-dideoxyguanosine-5′-triphosphate to the viral polymerase
13. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement
14. Woodchuck hepatitis virus infections: Very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte
15. Analysis of the earliest steps of hepadnavirus replication: Genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity
16. Lamivudine therapy of WHV-infected woodchucks
17. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver
18. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus
19. Demonstration of duck hepatitis B virus in bile duct epithelial cells: Implications for pathogenesis and persistent infection
20. Nucleic acid related compounds. 114. Synthesis of 2,6-(disubstituted)purine-2′,3′-dideoxynucleosides and selected cytotoxic, anti-hepatitis B, and adenosine deaminase substrate activities
21. Viral DNA synthesis
22. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification
23. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus
24. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: Drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles
25. Experimental in ovo transmission of duck hepatitis B virus
26. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells
27. Diurnal rhythms of plasma corticosterone concentrations in racing pigeons (Columba livia domestica) exposed to different light regimens, and the influence of frequent blood sampling
28. Diurnal changes in the plasma concentrations of corticosterone, luteinizing hormone and progesterone during sexual development and the ovulatory cycle of Khaki Campbell ducks
29. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway
30. Low dynamic state of viral competition in a chronic avian hepadnavirus infection
31. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis